


Antibody-drug Conjugate (ADC) Products
Antibody-drug conjugates (ADCs) belong to a new class of highly potent biopharmaceutical drugs designed as targeted therapy for the treatment of cancer patients. A typical ADC consists of three components: a target specific monoclonal antibody attached to a cytotoxic drug by the chemical linker. The antibody specifically targets a certain tumor marker (e.g. a protein that, ideally, is only to be found in or on tumor cells) , track this protein in the body and attach itself to the surface of cancer cell. The biochemical reaction between the antibody and the target protein (antigen) triggers a signal in the tumor cell, which then absorbs or internalizes the antibody together with the cytotoxin. After the ADC is internalized, the cytotoxic drug is released and kills the cancer cell. Typical examples are Brentuximab vedotin (SGN35), Trastuzumab-emtansine (T-DM1), Inotuzumab ozogamicin (CMC-544) and Gemtuzumab ozogamicin.
Creative Biolabs scientists are focusing on applying excellent science and technology to discover and develop potential new ADCs with the goal of becoming first-in-class therapeutics. We also provide custom ADCs design and construction services. Besides expression and purification of ADCs, we also provided HPLC/ELISA/TFC-MS/MS analysis for free drug and pharmacokinetics research.
- anti-HIgG(Fc)-N-MMAF ADC (ADC-1001-SHz)
-
- Target: human IgG Fc
- Linker: NC
- Drug: MMAF (Monomethyl auristatin F)
- anti-HIgG(Fc)-C-MMAF ADC (ADC-1002-SHz)
-
- Target: human IgG Fc
- Linker: CL
- Drug: MMAF (Monomethyl auristatin F)
- anti-HIgG(Fc)-C-MMAE ADC (ADC-1003-SHz)
-
- Target: human IgG Fc
- Linker: CL
- Drug: MMAE (Monomethyl auristatin E)
- anti-HIgG(Fc)-C-MD10 ADC (ADC-1004-SHz)
-
- Target: human IgG Fc
- Linker: CL
- Drug: MD10 (monomethyl dolastatin 10 )
- anti-HIgG(Fc)-C-DMSA ADC (ADC-1005-SHz)
-
- Target: human IgG Fc
- Linker: CL
- Drug: DMSA (duocarmycin SA)
- anti-HIgG(Fc)-C-DMDM ADC (ADC-1006-SHz)
-
- Target: human IgG Fc
- Linker: CL
- Drug: DMDM (duocarmycin DM)
- anti-HIgG(Fc)-C-PNU ADC (ADC-1007-SHz)
-
- Target: human IgG Fc
- Linker: CL
- Drug: PNU-159682
- anti-HIgG(Fc)-N-DM1 ADC (ADC-1008-SHz)
-
- Target: human IgG Fc
- Linker: NC
- Drug: DM1
- anti-HIgG(Fc)Fab-N-MMAF ADC (ADC-1009-SHFz)
-
- Target: human IgG Fc
- Linker: NC
- Drug: MMAF (Monomethyl auristatin F)
- anti-HIgG(Fc)Fab-C-MMAF ADC (ADC-1010-SHFz)
-
- Target: human IgG Fc
- Linker: CL
- Drug: MMAF (Monomethyl auristatin F)
- anti-HIgG(Fc)Fab-C-MMAE ADC (ADC-1011-SHFz)
-
- Target: human IgG Fc
- Linker: CL
- Drug: MMAE (Monomethyl auristatin E)
- anti-HIgG(Fc)Fab-C-DMSA ADC (ADC-1012-SHFz)
-
- Target: human IgG Fc
- Linker: CL
- Drug: DMSA (duocarmycin SA)
- anti-HIgG(Fc)Fab-C-DMDM ADC (ADC-1013-SHFz)
-
- Target: human IgG Fc
- Linker: CL
- Drug: DMDM (duocarmycin DM)
- anti-HIgG(Fc)Fab-C-PNU ADC (ADC-1014-SHFz)
-
- Target: human IgG Fc
- Linker: CL
- Drug: PNU-159682
- anti-HIgG(Fc)Fab-N-DM1 ADC (ADC-1015-SHFz)
-
- Target: human IgG Fc
- Linker: NC
- Drug: DM1
- anti-HIgG(Fc)Fab-N-AAMT ADC (ADC-1016-SHFz)
-
- Target: human IgG Fc
- Linker: NC
- Drug: Alfa-amanitin
- anti-HIgG(Fab)-C-MMAE ADC (ADC-1017-SHz)
-
- Target: human IgG Fab
- Linker: CL
- Drug: MMAE (Monomethyl auristatin E)
- anti-HIgG(Fab)-N-DM1 ADC (ADC-1018-SHz)
-
- Target: human IgG Fab
- Linker: NC
- Drug: DM1
- anti-MIgG(Fc)-N-MMAF ADC (ADC-1019-SMz)
-
- Target: mouse IgG Fc
- Linker: NC
- Drug: MMAF (Monomethyl auristatin F)
- anti-MIgG(Fc)-C-MMAF ADC (ADC-1020-SMz)
-
- Target: mouse IgG Fc
- Linker: CL
- Drug: MMAF (Monomethyl auristatin F)
- anti-MIgG(Fc)-C-MMAE ADC (ADC-1021-SMz)
-
- Target: mouse IgG Fc
- Linker: CL
- Drug: MMAE (Monomethyl auristatin E)
- anti-MIgG(Fc)-C-MD10 ADC (ADC-1022-SMz)
-
- Target: mouse IgG Fc
- Linker: CL
- Drug: MD10 (monomethyl dolastatin 10 )
- anti-MIgG(Fc)-C-DMSA ADC (ADC-1023-SMz)
-
- Target: mouse IgG Fc
- Linker: CL
- Drug: DMSA (duocarmycin SA)
- anti-MIgG(Fc)-C-DMDM ADC (ADC-1024-SMz)
-
- Target: mouse IgG Fc
- Linker: CL
- Drug: DMDM (duocarmycin DM)
- anti-MIgG(Fc)-C-PNU ADC (ADC-1025-SMz)
-
- Target: mouse IgG Fc
- Linker: CL
- Drug: PNU-159682
- anti-MIgG(Fc)-N-DM1 ADC (ADC-1026-SMz)
-
- Target: mouse IgG Fc
- Linker: NC
- Drug: DM1
- anti-MIgG(Fc)Fab-N-MMAF ADC (ADC-1027-SMFz)
-
- Target: mouse IgG Fc
- Linker: NC
- Drug: MMAF (Monomethyl auristatin F)
- anti-MIgG(Fc)Fab-C-MMAF ADC (ADC-1028-SMFz)
-
- Target: mouse IgG Fc
- Linker: CL
- Drug: MMAF (Monomethyl auristatin F)
- anti-MIgG(Fc)Fab-C-MMAE ADC (ADC-1029-SMFz)
-
- Target: mouse IgG Fc
- Linker: CL
- Drug: MMAE (Monomethyl auristatin E)
- anti-MIgG(Fc)Fab-C-DMDM ADC (ADC-1030-SMFz)
-
- Target: mouse IgG Fc
- Linker: CL
- Drug: DMDM (duocarmycin DM)
- anti-MIgG(Fc)Fab-N-DM1 ADC (ADC-1031-SMFz)
-
- Target: mouse IgG Fc
- Linker: NC
- Drug: DM1
- anti-RIgG(Fc)-N-MMAF ADC (ADC-1032-SRz)
-
- Target: rabbit IgG Fc
- Linker: NC
- Drug: MMAF (Monomethyl auristatin F)
- anti-RIgG(Fc)Fab-N-MMAF ADC (ADC-1033-SRFz)
-
- Target: rabbit IgG Fc
- Linker: NC
- Drug: MMAF (Monomethyl auristatin F)
- anti-RIgG(HL)-N-MMAF ADC (ADC-1034-SRz)
-
- Target: rabbit IgG(H+L)
- Linker: NC
- Drug: MMAF (Monomethyl auristatin F)
- anti-RIgG(HL)-C-MMAF ADC (ADC-1035-SRz)
-
- Target: rabbit IgG(H+L)
- Linker: CL
- Drug: MMAF (Monomethyl auristatin F)
- anti-RIgG(HL)-C-MMAE ADC (ADC-1036-SRz)
-
- Target: rabbit IgG(H+L)
- Linker: CL
- Drug: MMAE (Monomethyl auristatin E)
- anti-RIgG(HL)Fab-N-MMAF ADC (ADC-1037-SRFz)
-
- Target: rabbit IgG(H+L)
- Linker: NC
- Drug: MMAF (Monomethyl auristatin F)
- anti-RIgG(HL)Fab-C-MMAF ADC (ADC-1038-SRFz)
-
- Target: rabbit IgG(H+L)
- Linker: CL
- Drug: MMAF (Monomethyl auristatin F)
- anti-Rat IgG(Fc)-N-MMAF ADC (ADC-1039-SRtz)
-
- Target: rat IgG Fc
- Linker: NC
- Drug: MMAF (Monomethyl auristatin F)
- anti-Rat IgG(Fc)-C-MMAF ADC (ADC-1040-SRtz)
-
- Target: rat IgG Fc
- Linker: CL
- Drug: MMAF (Monomethyl auristatin F)
- anti-Rat IgG(Fc)Fab-N-MMAF ADC (ADC-1041-SRtFz)
-
- Target: rat IgG Fc
- Linker: NC
- Drug: MMAF (Monomethyl auristatin F)
- anti-Rat IgG(Fc)Fab-C-MMAF ADC (ADC-1042-SRtFz)
-
- Target: rat IgG Fc
- Linker: CL
- Drug: MMAF (Monomethyl auristatin F)
- anti-Rat IgG(Fc)Fab-C-MMAE ADC (ADC-1043-SRtFz)
-
- Target: rat IgG Fc
- Linker: CL
- Drug: MMAE (Monomethyl auristatin E)
- anti-Rat IgG(Fc)Fab-C-DMDM ADC (ADC-1044-SRtFz)
-
- Target: rat IgG Fc
- Linker: CL
- Drug: DMDM (duocarmycin DM)
- anti-Rat IgG(HL)-N-MMAF ADC (ADC-1045-SRtz)
-
- Target: rat IgG(H+L)
- Linker: NC
- Drug: MMAF (Monomethyl auristatin F)
- anti-Rat IgG(HL)Fab-N-MMAF ADC (ADC-1046-SRtFz)
-
- Target: rat IgG(H+L)
- Linker: NC
- Drug: MMAF (Monomethyl auristatin F)
- anti-Rat IgG(HL)Fab-C-MMAF ADC (ADC-1047-SRtFz)
-
- Target: rat IgG(H+L)
- Linker: CL
- Drug: MMAF (Monomethyl auristatin F)
- Pironetin (ADCsR-218CL)
-
- Formula: C19H32O4
- CAS No.: 151519-02-7
- Podophyllotoxin (ADCsR-220CL)
-
- Formula: C22H22O8
- CAS No.: 518-28-5
- Polyketomycin (ADCsR-221CL)
-
- Formula: C44H48O18
- CAS No.: 200625-47-4
- Pseudolaric acid B (ADCsR-222CL)
-
- Formula: C23H28O8
- CAS No.: 82508-31-4
- Pseurotin A (ADCsR-223CL)
-
- Formula: C22H25NO8
- CAS No.: 58523-30-1
- epsilon-Amanitin (ADCsR-224CL)
-
- Formula: C39H53N9O14S
- CAS No.: 21705-02-2
- Puwainaphycin F (ADCsR-225CL)
-
- Formula: C53H87N13O15
- Pyrrolobenzodiazepine Dimer (ADCsR-226CL)
-
- Formula: C31H32N4O6
- Quinaldopeptin (ADCsR-227CL)
-
- Formula: C62H78N14O14
- CAS No.: 130743-07-6
- Rebeccamycin (ADCsR-228CL)
-
- Formula: C27H21Cl2N3O7
- CAS No.: 93908-02-2
- Ro 5-3335 (ADCsR-229CL)
-
- Formula: C13H10ClN3O
- CAS No.: 30195-30-3
- Safracin B (ADCsR-230CL)
-
- Formula: C28H36N4O7
- CAS No.: 87578-99-2
- Sandramycin (ADCsR-231CL)
-
- Formula: C60H76N12O16
- CAS No.: 100940-65-6
- Sanguinarine (ADCsR-232CL)
-
- Formula: C20H14NO4
- CAS No.: 2447-54-3
- Sinefungin (ADCsR-233CL)
-
- Formula: C15H23N7O5
- CAS No.: 58944-73-3
- Telomestatin (ADCsR-234CL)
-
- Formula: C26H14N8O7S
- CAS No.: 265114-54-3
- Thiocolchicine (ADCsR-235CL)
-
- Formula: C22H25NO5S
- CAS No.: 2730-71-4
- Tolytoxin (ADCsR-236CL)
-
- Formula: C46H75NO13
- Tripolin A (ADCsR-237CL)
-
- Formula: C15H11NO3
- CAS No.: 1148118-92-6
- Tubastatin A HCl (ADCsR-239CL)
-
- Formula: C20H21N3O2*HCl
- CAS No.: 1310693-92-5
- Anti-EGFR (ABT-806)-Mc-MMAE ADC (ABT-414) (ADC-L001)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
-
- Target: AGS-16
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
-
- Target: Nectin-4
- Linker: mc-val-cit-PABC (cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
-
- Target: CD37
- Linker: mc-val-cit-PABC (cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-SCL44A4-mc-vc-MMAE ADC (AGS-5ME) (ADC-L007)
-
- Target: SCL44A4
- Linker: mc-vc (maleimidocaproyl-valine-alanine)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CA6 (3ee9)-mc-vc-MMAE ADC (BAY-79-4620) (ADC-L008)
-
- Target: CA6
- Linker: mc-vc (maleimidocaproyl-valine-alanine)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-Mesothelin (MF-T)-DM4 ADC (BAY 94-9343) (ADC-L009)
-
- Target: mesothelin
- Linker: disulfide
- Drug: DM4 (N2'-Deacetyl-N2'-(4-mercapto-4- methyl-1-oxopentyl)maytansine)
-
- Target: CD-138(=SDC1)
- Linker: SPDB (N-succinimidyl 4-(2-pyridyldithio)butyrate)
- Drug: DM4 (N2'-Deacetyl-N2'-(4-mercapto-4- methyl-1-oxopentyl)maytansine)
-
- Target: CD70
- Linker: cleavable di-peptide linker
- Drug: Duocarmycins
-
- Target: mesothelin
- Linker: cleavable di-peptide linker
- Drug: Duocarmycins
- Anti-Tim-1 (CR014)-vc-MMAE ADC (CDX-014) (ADC-L014)
-
- Target: Tim-1
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
-
- Target: Tissue factor
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-EGFR (J2898A)-SMCC-DM1 ADC (IMGN289) (ADC-L016)
-
- Target: EGFR
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto- 1-oxopropyl)maytansine)
-
- Target: CD56
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto- 1-oxopropyl)maytansine)
-
- Target: FOLR1
- Linker: sulfo-SPDB (sulfosuccinimidyl N-succinimidyl-4-(2-pyridyldithio)butyrate)
- Drug: DM4 (N2'-Deacetyl-N2'-(4-mercapto-4- methyl-1-oxopentyl)maytansine)
- Anti-CD37 (K7153A)-SMCC-DM1 ADC (IMGN529) (ADC-L019)
-
- Target: CD37
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto- 1-oxopropyl)maytansine)
- Anti-CD66e-Mc-SN-38 ADC (IMMU-130/-SN-38) (ADC-L020)
-
- Target: CD66e
- Linker: mc (maleimidocaproyl)
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
- Anti-EhpA2 (1C1)-Mc-MMAF ADC (MEDI-547) (ADC-L023)
-
- Target: EhpA2
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
-
- Target: CD22
- Linker: acetyl butyrate linker
- Drug: calicheamicin
-
- Target: CD33
- Linker: acetyl butyrate linker
- Drug: calicheamicin
-
- Target: STEAP1
- Linker: mc-val-cit-PABC (cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD22 (CR011)-vc-MMAE ADC (RG7593) (ADC-L028)
-
- Target: CD22
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD79b (SN8)-vc-MMAE ADC (RG7596) (ADC-L029)
-
- Target: CD79b
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
-
- Target: HER2
- Linker: mcc (Maleimidomethyl cyclohexane-1- carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto- 1-oxopropyl)maytansine)
-
- Target: CD33
- Linker: mc-vc (maleimidocaproyl-valine-alanine)
- Drug: pyrrolobenzodiazepine (PBD) dimers SGD-1882
- Anti-CD19 (hBU12)-Mc-MMAF ADC (SGN-19A) (ADC-L034)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
-
- Target: GCC
- Linker: mc-val-cit-PABC (cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl )
- Drug: MMAE (Monomethyl auristatin E)
-
- Target: CD30
- Linker: mc-val-cit-PABC (cleavable maleimidocaproyl-valyl-citrullinyl-p-aminobenzyloxycarbonyl )
- Drug: MMAE (Monomethyl auristatin E)
-
- Target: HER2
- Linker: vc (valine-citrulline)
- Drug: Duocarmycins
- Anti-cKit-maitansine ADC (LOP628) (ADC-L039)
-
- Target: cKit
- Linker: non-cleavable linker
- Drug: maitansine
-
- Target: zinc transporter LIV-1
- Linker: vc (valine-citrulline)
- Drug: MMAE (Monomethyl auristatin E)
-
- Target: CD19
- Linker: mc-vc (maleimidocaproyl-valine-alanine)
- Drug: pyrrolobenzodiazepine (PBD) dimers SGD-1882
-
- Target: DLL3
- Linker: mc-vc (maleimidocaproyl-valine-alanine)
- Drug: pyrrolobenzodiazepine (PBD) dimer SCX
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.